Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142996 |
| CAS No | NA |
| Mol.F. | C187H290N46O60 |
| Mol.Wt. | 4142.64 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142997 |
| CAS No | NA |
| Mol.F. | C9H5CI2N5O2 |
| Mol.Wt. | 286.07 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142998 |
| CAS No | NA |
| Mol.F. | C9H4CI2N4O3 |
| Mol.Wt. | 287.06 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142999 |
| CAS No | NA |
| Mol.F. | C16H8CI4N6O2 |
| Mol.Wt. | 458.08 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143000 |
| CAS No | NA |
| Mol.F. | C9H6Cl2N6O |
| Mol.Wt. | 285.09 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143001 |
| CAS No | NA |
| Mol.F. | C9H8Cl2N6O |
| Mol.Wt. | 287.10 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143002 |
| CAS No | NA |
| Mol.F. | C9H6Cl2N6O2 |
| Mol.Wt. | 301.09g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143003 |
| CAS No | NA |
| Mol.F. | C23H10Cl6N6O3 |
| Mol.Wt. | 631.07 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143004 |
| CAS No | NA |
| Mol.F. | C9H6Cl2N6O2 |
| Mol.Wt. | 301.09g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143005 |
| CAS No | NA |
| Mol.F. | C16H8Cl4N6O2 |
| Mol.Wt. | 458.08 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143006 |
| CAS No | NA |
| Mol.F. | C19H13Cl4N11O |
| Mol.Wt. | 553.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143007 |
| CAS No | NA |
| Mol.F. | C19H13Cl4N11O |
| Mol.Wt. | 553.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143008 |
| CAS No | NA |
| Mol.F. | C8H7Cl2N5O2 |
| Mol.Wt. | 276.08 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143009 |
| CAS No | NA |
| Mol.F. | C16H13F3N4O4S |
| Mol.Wt. | 414.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143010 |
| CAS No | NA |
| Mol.F. | C7H5N3O2 |
| Mol.Wt. | 163.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143011 |
| CAS No | NA |
| Mol.F. | C14H11ClN4O2S |
| Mol.Wt. | 334.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |